Takeshima Hideyuki, Niwa Tohru, Takahashi Takamasa, Wakabayashi Mika, Yamashita Satoshi, Ando Takayuki, Inagawa Yuki, Taniguchi Hirokazu, Katai Hitoshi, Sugiyama Toshiro, Kiyono Tohru, Ushijima Toshikazu
Division of Epigenomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Third Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Cancer Lett. 2015 Feb 1;357(1):328-338. doi: 10.1016/j.canlet.2014.11.038. Epub 2014 Nov 22.
A field for cancerization, or a field defect, is formed by the accumulation of genetic and epigenetic alterations in normal-appearing tissues, and is involved in various cancers, especially multiple cancers. Epigenetic alterations are frequently present in chronic inflammation-exposed tissues, but information on individual genes involved in the formation of a field defect is still fragmental. Here, using non-cancerous gastric tissues of cancer patients, we isolated 16 aberrantly methylated genes, and identified chromatin remodelers ACTL6B and SMARCA1 as novel genes frequently methylated in non-cancerous tissues. SMARCA1 was expressed at high levels in normal gastric tissues, but was frequently silenced by aberrant methylation in gastric cancer cells. Moreover, somatic mutations of additional chromatin remodelers, such as ARID1A, SMARCA2, and SMARCA4, were found in 30% of gastric cancers. Mutant allele frequency suggested that the majority of cancer cells harbored a mutation when present. Depletion of a chromatin remodeler, SMARCA1 or SMARCA2, in cancer cell lines promoted their growth. These results showed that epigenetic and genetic alterations of chromatin remodelers are induced at an early stage of carcinogenesis and are frequently involved in the formation of a field defect.
癌化区域或场缺陷是由看似正常的组织中遗传和表观遗传改变的积累形成的,并且与各种癌症有关,尤其是多种癌症。表观遗传改变经常出现在暴露于慢性炎症的组织中,但关于参与场缺陷形成的单个基因的信息仍然支离破碎。在这里,我们使用癌症患者的非癌性胃组织,分离出16个异常甲基化的基因,并鉴定出染色质重塑因子ACTL6B和SMARCA1是在非癌性组织中经常甲基化的新基因。SMARCA1在正常胃组织中高表达,但在胃癌细胞中经常因异常甲基化而沉默。此外,在30%的胃癌中发现了其他染色质重塑因子的体细胞突变,如ARID1A、SMARCA2和SMARCA4。突变等位基因频率表明,大多数癌细胞在存在突变时都携带了突变。在癌细胞系中敲除染色质重塑因子SMARCA1或SMARCA2可促进其生长。这些结果表明,染色质重塑因子的表观遗传和遗传改变在致癌作用的早期就被诱导,并且经常参与场缺陷的形成。